https://www.dccv.de/betroffene-angehoerige/leben-mit-einer-ced/infektion... people especially those with chronic diseases such as IBD and/or who are taking immunosuppressant medications migth be concerned about the novel Coronavirus 2019 (COVID-19).
EFCCA organised a symposium on “Digital Health and Data: IBD patients´ view and perspectives” which took place during the ECCO Congress on 14 February 2020 from 14-15h in Vienna, Austria.
This was an unique event bringing together IBD patients, healthcare providers and other stakeholder in order to start discussions on how digital health and big data can contribute in delivering more personalised care and offering a higher quality of life of patients with IBD.
The EFCCA Strategy Plan for the period of 2019-2022 provides direction to our member associations and informs stakeholders of EFCCA’s Vision, Mission, Values and the Priority areas EFCCA intends to focus on in the coming four years and how it plans to implement them.
New survey on the indirect costs of IBD. The aim of the study is to assess the influence of IBD on the patients productivity at work and relevant costs for society. www.ibdcosts.eu Within the framework of World IBD Day 2019 the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) is supporting a new study which aims to assess the indirect or invisible costs of Crohn’s disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease (IBD).
There are some topics that are hard to discuss, for which people may not want to share their opinions. Surgery in people with Inflammatory Bowel Disease (IBD) is one of these neglected topics. It is, however, extremely relevant and important to collect information about the perception of surgery, the impact on the quality of life, and worries about it.
The results of this important survey have now been published in the in the Colorectal Disease Journal.
EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We believe patient groups can help us understand patients’ unique perspectives by collecting and presenting patients’ and carers/care-givers’ views and experiences by engaging with a wide range of patients.
We are proud to announce that the third video animation of our My IBD Journey series is now available. The video entitled “Mission: Remission” explains the different types of remission and provides advice on how you can work towards achieving remission, and the importance of staying on track with your treatment.
By subscribing to our questionnaires, you agree with our policy for the treatment of your data.
Questionnaire BAB German language
Questionnaire BAB Spanish language
Questionnaire BAB Portoguese language
Questionnaire BAB Italian language
The pharmaceutical company, Pfizer, has launched a call for proposal within the framework of the "Independent Grants for Learning & Change".
The call is for proposals on "Appropriate Immunisations in Adult Patients with Immune-Mediated Inflammatory Conditions".
Follow the link for more informatio: https://www.pfizer.com/sites/default/files/rfp_files/IGLC_RFP_2018RA2_Im...